ARTICLE | Company News
Anavex, Israel Institute for Biological Research (IIBR) deal
April 7, 2014 7:00 AM UTC
IIBR's Life Science Research Israel Ltd. subsidiary granted Anavex exclusive, worldwide development and commercialization rights to AF710B and additional backup compounds. The sigma-1 receptor and ...